Actinium Pharmaceuticals
ATNM
ATNM
42 hedge funds and large institutions have $11.5M invested in Actinium Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
33% less capital invested
Capital invested by funds: $17.1M → $11.5M (-$5.65M)
Holders
42
Holding in Top 10
–
Calls
$3.01M
Puts
$2.84M
Top Buyers
| 1 | +$282K | |
| 2 | +$90.4K | |
| 3 | +$84K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$58.9K |
| 5 |
BlackRock
New York
|
+$54.6K |
Top Sellers
| 1 | -$199K | |
| 2 | -$158K | |
| 3 | -$145K | |
| 4 |
WANY
Wealthspire Advisors (New York)
New York
|
-$127K |
| 5 |
BC
BIT Capital
Berlin,
Germany
|
-$125K |